دکتر حمیدرضا دهقان منشادی

متخصص رادیوتراپی انکولوژی

دارای بورد تخصصی رشته رادیوتراپی انکولوژی

موسس اولین مرکز براکی تراپی در ایران

فعالیت های علمی

مراتب دانشگاهی

۲۰۰۸                                       Fellowship in Brachytherapy,

                                               European Society for Radiation-oncology, Belgium

 

۲۰۰۲- ۲۰۰۵                            Specialized Board in Radiation-oncology,

                                               Tehran University of Medical Sciences (TUMS), Iran 

 

۱۹۸۸-۱۹۹۵                             Medicine,

                                               Shahid Beheshti University of Medical Sciences (SBMU), Iran 

سوابق کاری

Specialized Board in Radiation-oncology,

                                               Tehran University of Medical Sciences (TUMS), Iran 

سوابق آموزشی

۲۰۱۱-۲۰۱۳                          Scientific Representative of Electa-Neucleotron in Middle East

۲۰۱۲                                   Brachytherapy Educational Course, Pakistan

۲۰۱۱-۲۰۱۳                          Oncology Course for Intern Students of Shahid Beheshti                                                     University

پایان نامه های دانشجویی

  • Study of Tissue Inconsistency on Distribution and SAVI Applicator Dose in Breast Brachytherapy Using Monte Carlo Method (Islamic Azad University, 2016)
  • Pharmacogenetics of Cyclophosphamide in Breast Cancer Patients (National Institute of Genetic Engineering and Biotechnology, 2015)
  • Pharmacogenetics of Doxorubicin in Breast Cancer Patients (National Institute of Genetic Engineering and Biotechnology, 2015)
  • Providing a Model for Correction of Cervix Cancer Brachytherapy Design Based on Anatomic Alterations, (Shahid Beheshti University of Medical Sciences. 2014)
  • Evaluation of accuracy of the delivered dose to rectum in HDR brachytherapy in treatment of endometrial and cervix cancers using Flexiplan 3D treatment program (Tehran Uinversity of Medical Sciences, 2010) 
  • Study of Major Stress on Emerging of Breast Cancer in 20-50 Years old Women (Iran University of Medical Sciences, 2008)

طرح های تحقیقاتی

  • Pharmacogenetics of Breast cancer among Iranian population (ongoing)

 

  • Identification of molecular markers for cancer susceptibility among Iranian

        Population (ongoing)

 

  • Outcomes of survival of High-Dose-Rate Brachytherapy (Iridium-192) in the

        treatment of recurrent Malignant Gliomas in Shohada-Tajrish Hospital (2011)

شرکت در کنگره های علمی

Conference Presentations

۲۰۱۷                  European Cancer Summit, Italy

۲۰۱۶                  ESMO Asia, Singapore

۲۰۱۶                  ESTRO 35 Congress, Italy

۲۰۱۵                  ESMO Asia, Singapore

۲۰۱۴                  EMS Scientific Exchange Meeting Gastric and Thoracic Cancer, UAE

۲۰۱۴                  ESTRO 33 Congress, Austria

۲۰۱۳                  ۲nd ESTRO Forum, Switzerland

۲۰۱۳                  Brachytherapy Middle East User Group Meeting, UAE

۲۰۱۲                  Chief Member of Brachytherapy Conference, UAE

۲۰۱۲                  ۳rd Asian Breast Cancer Congress, India

۲۰۱۲                  International Multidiciplinary Cancer Congress, Iran

۲۰۱۲                  ۴th National Congress of Iranian Society of Gynaecology-oncology, Iran

۲۰۱۱                  ۱۳th World Congress on Gastrointestinal Cancer, Spain

۲۰۱۰                  ۳rd Congress of Iranian Society of Women Cancers, Iran

۲۰۱۰                  ۳D Image-Based Brachytherapy in Gynaecological Malignancies, Poland

۲۰۰۹                   ۴th Best of ASCO Congress, Lebanon

۲۰۰۹                  Continued Training Programs in Chemotherapy, Iran

۲۰۰۹                   Continued Training Programs in Trophoblastic Diseases, Iran

۲۰۰۹                  International Congress of Iranian Society of Women Cancers, Iran

۲۰۰۸                   Continued Training Programs in Radiotherapy and Chemotherapy for

                           Treatment of Cervix Cancer and its recurrence, Iran

۲۰۰۸                   Continued Training Programs in Cervix Cancer and Pre-cancer lesions,

                           Iran

۲۰۰۶                   Conference on Soft Tissue Sacrum News, Iran

۲۰۰۶                   Annual Congress of Iranian Society of Pathology, Iran

۲۰۰۶                   Conference on the Role of the Endocrine Therapy in Breast Cancer, Iran

۲۰۰۵                   Conference on Gastrointestinal Cancers, Iran  

۲۰۰۵                   The First national Congress on Gyncology-oncology, Iran

۲۰۰۵                   Monthly Conference of Iranian Society of Women Cancers, Iran

۲۰۰۱                   ۱۲th European Students Conference for Medical Students, Germany

مقالات علمی

۱٫      M. Mobaraki, A. Faraji, M. Zare, P. Dolati, M. Ataei and H. R. Dehghan Manshadi*. Molecular Mechanisms of Cardiotoxicity: A Review on Major Side-effect of Doxorubicin. Indian Journal of Pharmaceutical Sciences 2017; 79(3):335

 

  1. Abolfazl Faraji, Hamid Reza Dehghan Manshadi*, Maryam Mobaraki, Mahkameh Zare, Massoud Houshmand*. Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients. PLoS ONE 2016; 11(12):e0168519.
  1. M. Mobaraki, H. R. Dehghan Manshadi, A. Faraji, M. Zare, M. H. Sanati*. Impact of GSTP1 and ABCC4 Genes Polymorphism on Outbreak of Cyclophosphamide-based Chemotherapy-induced Grade 3/4 Febrile Neutropenia in Iranian Breast Cancer Patients. Annals of Oncology 2016; 27(Supp 9):39P.

 

  1. Abolfazl Faraji, Hamid Reza Dehghan Manshadi*, Maryam Mobaraki, Mahkameh Zare, Massoud Houshmand*. Effect of ABCB1 and SLC22A16 genes polymorphism in outbreak of doxorubicin-based chemotherapy-induced grade 3/4 febrile neutropenia in Iranian breast cancer patients. Annals of Oncology 2016; 27(Supp 9):40P.

 

  1. M. Zare, M. Aghili, B. Kalaghchi, H. Dehghan Manshadi, E. Esmati. Efficacy of gabapentin for prevention of paclitaxel induced neuropathy: randomized double blind, phase 3 trial. Annals of Oncology 2016; 27(Supp 9):91P.
  1. M. Mobaraki, H. R. Dehghan Manshadi, A. Faraji, M. Zare, M. H. Sanati*. The Association of Polymorphism in GSTP1 and ABCC4 Genes with the Cyclophosphamide-induced Neutropenia in Iranian Breast Cancer Patients. Under review at Pharmacogenomics, 2016

۷٫      Zahra Siavashpour, Mahmoud Reza Aghamiri, Ramin Jaberi, Hamid Reza Dehghan Manshadi, Reza Ghaderi, Christian Kirisits. Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy. J Contemp Brachytherapy 2016; 8(2):135–۱۴۲٫

 

۸٫      Zahra Siavashpour, Mahmoud Reza Aghamiri, Ramin Jaberi, Naser ZareAkha, Hamid Reza Dehghan Manshadi, Christian Kirisits, Mahbod Sedaghat. A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 3, 2016.

۹٫      Zahra Siavashpour*, Mahmoud Reza Aghamiri, Ramin Jaberi, Hamid Reza DehghanManshadi, MahbodSedaghat, Christian Kirisits. Evaluating the utility of ‘‘۳D Slicer’’ as a fast and independent tool to assess intrafractional organ dose variations in gynecological brachytherapy. Brachytherapy, 2016.

۱۰٫  Hamid Reza Dehghan Manshadi, Marzieh Lashkari, Mahkameh Zare, Ramin Jaberi, Rubik Behbo, Ehsan Karbasi. High-Dose-Rate brachytherapy (HDR-BT) with neoadjuvant chemoradiation for advanced rectal cancer. IMJ-Health 2016; 2 (3).

  1. PO-1010: Siavashpour, M.R. Aghamiri, R. Jaberi, N. ZareAkha, H.R. Dehghan Manshadi. Full or empty bladder preference, from this OAR dose viewpoint, in different Tandem length ICBT applicator insertion. Radiotherapy and Oncology, 2014, Volume 111 , S148 – S149.

 

  1. PO-0960: Siavashpour, M.R. Aghamiri, R. Jaberi, N. Zare Akha, H.R. Dehghan Manshadi, S. Karimkhani Zand. Effect of bladder fullness in brachytherapy procedure for EBRT complete response treated cervical cancer patients. Radiotherapy and Oncology, 2013, Volume 106, S370.
  1. Hariri, M. R. Aghamiri, S. Najarian, R. Jaberi, M. Azmi, H. R. Dehghan, S. Hajizadeh. Endoscopic Guided Brachytherapy in Gastric Cancer. World Congress on Medical Physics and Biomedical Engineering, 2009, Volume 25, pp 220-223.
  1. PO55: Sanaz Hariri, Mahmood Reza Aghamiri, Siamak Najarian, Ramin Jaberi, Mehrdad Azmi, Hamid Reza Dehghan, Siamak Hajizadeh. A novel approach to manage gastric adenocarcinoma. Brachytherapy, 2009, Volume 8, Issue 2, 158-159.

 

  1. Samiee, MD H.R. Dehghan Manshadi*, MD R. Jaberi, MS, A.A. Sharafi, PhD A.P. Meysami, MD, MPH . Gharaati, PhD. Rectal Dose Evaluation and Comparison between In-Vivo & Planning Dosimetry in Patients with Cervical & Endometrial Cancer who Received Brachytherapy Treatment. Razi Journal of Medical Sciences RJMS, 2006, 12(49): 89-96

 

  1. Zahar Siavashpour, Mahmoud Reza Aghamiri, Ramin Jaberi, Hamid Reza Dehghan Manshadi, Naser ZareAkha, Mozafar Darvishi, Christian Kirisits. Evaluation of organ at risks received dose based on organ volume status in 3D GYN intracavitary brachytherapy according to the GEC-ESTRO recommendation on contouring and dose constrains. Submitted to Japanees journal of radiology

This post is also available in: English